Francisco Fuster

Unit:

Cancer Science

Position:

Alumni - Visiting Scientist

Office:

CL01C74

Telephone:

+34 93 40 39954

Email:

francisco.fuster@irbbarcelona.org

Left IRB Barcelona in March 2022

Research Group

Genome Data Science

Cancer Science

Selected group publications

Mutational signatures are markers of drug sensitivity of cancer cells

Levati, J; Salvadores, M; Fuster-Tormo, F; Supek, F

Nature Communications

(1 )

2926 -

(2022)

Loss of the abasic site sensor HMCES is synthetic lethal with the activity of the APOBEC3A cytosine deaminase in cancer cells

Biayna, J; Garcia-Cao, I; Alvarez, MM; Salvadores, M; Espinosa-Carrasco, J; McCullough, M; Supek, F; Stracker, TH

Plos Biology

(3 )

e3001176 -

(2021)

DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers

Mas-Ponte, D; Supek, F

Nature Genetics

(9 )

958 -

(2020)

TP53-dependent toxicity of CRISPR/Cas9 cuts is differential across genomic loci and can confound genetic screening

Alvarez, MM; Biayna, J; Supek, F

Nature Communications

(1 )

4520 -

(2022)

The impact of rare germline variants on human somatic mutation processes

Vali-Pour, M; Lehner, B; Supek, F

Nature Communications

(1 )

3724 -

(2022)

Mutational signatures are markers of drug sensitivity of cancer cells

Levati, J; Salvadores, M; Fuster-Tormo, F; Supek, F

Nature Communications

(1 )

2926 -

(2022)

Loss of the abasic site sensor HMCES is synthetic lethal with the activity of the APOBEC3A cytosine deaminase in cancer cells

Biayna, J; Garcia-Cao, I; Alvarez, MM; Salvadores, M; Espinosa-Carrasco, J; McCullough, M; Supek, F; Stracker, TH

Plos Biology

(3 )

e3001176 -

(2021)

DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers

Mas-Ponte, D; Supek, F

Nature Genetics

(9 )

958 -

(2020)

TP53-dependent toxicity of CRISPR/Cas9 cuts is differential across genomic loci and can confound genetic screening

Alvarez, MM; Biayna, J; Supek, F

Nature Communications

(1 )

4520 -

(2022)

The impact of rare germline variants on human somatic mutation processes

Vali-Pour, M; Lehner, B; Supek, F

Nature Communications

(1 )

3724 -

(2022)

Mutational signatures are markers of drug sensitivity of cancer cells

Levati, J; Salvadores, M; Fuster-Tormo, F; Supek, F

Nature Communications

(1 )

2926 -

(2022)